Abstract
The tumor suppressor p53 has evolved a MDM2-dependent feedback loop that promotes p53 protein degradation through the ubiquitin–proteasome system. MDM2 is an E3-RING containing ubiquitin ligase that catalyzes p53 ubiquitination by a dual-site mechanism requiring ligand occupation of its N-terminal hydrophobic pocket, which then stabilizes MDM2 binding to the ubiquitination signal in the DNA-binding domain of p53. A unique pseudo-substrate motif or “lid” in MDM2 is adjacent to its N-terminal hydrophobic pocket, and we have evaluated the effects of the flexible lid on the dual-site ubiquitination reaction mechanism catalyzed by MDM2. Deletion of this pseudo-substrate motif promotes MDM2 protein thermoinstability, indicating that the site can function as a positive regulatory element. Phospho-mimetic mutation in the pseudo-substrate motif at codon 17 (MDM2S17D) stabilizes the binding of MDM2 towards two distinct peptide docking sites within the p53 tetramer and enhances p53 ubiquitination. Molecular modeling orientates the phospho-mimetic pseudo-substrate motif in equilibrium over a charged surface patch on the MDM2 at Arg97/Lys98, and mutation of these residues to the MDM4 equivalent reverses the activating effect of the phospho-mimetic mutation on MDM2 function. These data highlight the ability of the pseudo-substrate motif to regulate the allosteric interaction between the N-terminal hydrophobic pocket of MDM2 and its central acidic domain, which stimulates the E3 ubiquitin ligase function of MDM2. This model of MDM2 regulation implicates an as yet undefined lid-kinase as a component of pro-oncogenic pathways that stimulate the E3 ubiquitin ligase function of MDM2 in cells.
Similar content being viewed by others
References
Adams J, Chen ZP, Van Denderen BJ, Morton CJ, Parker MW, Witters LA, Stapleton D, Kemp BE (2004) Protein Sci 13:155
Arva NC, Gopen TR, Talbot KE, Campbell LE, Chicas A, White DE, Bond GL, Levine AJ, Bargonetti J (2005) J Biol Chem 280:26776
Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA (2001) Proc Natl Acad Sci U S A 98:10037
Bottger V, Bottger A, Howard SF, Picksley SM, Chene P, Garcia-Echeverria C, Hochkeppel HK, Lane DP (1996) Oncogene 13:2141
Burch LR, Midgley CA, Currie RA, Lane DP, Hupp TR (2000) FEBS Lett 472:93
Burch L, Shimizu H, Smith A, Patterson C, Hupp TR (2004) J Mol Biol 337:129
Candeias MM, Malbert-Colas L, Powell DJ, Daskalogianni C, Maslon MM, Naski N, Bourougaa K, Calvo F, Fahraeus R (2008) Nat Cell Biol 10:1098
Chen J, Marechal V, Levine AJ (1993) Mol Cell Biol 13:4107
Craig AL, Chrystal JA, Fraser JA, Sphyris N, Lin Y, Harrison BJ, Scott MT, Dornreiter I, Hupp TR (2007) Mol Cell Biol 27:3542
Dornan D, Hupp TR (2001) EMBO Rep 2:139
Dyson HJ, Wright PE (2002) Curr Opin Struct Biol 12:54
Elenbaas B, Dobbelstein M, Roth J, Shenk T, Levine AJ (1996) Mol Med 2:439
Gannon JV, Greaves R, Iggo R, Lane DP (1990) EMBO J 9:1595
Gouet P, Courcelle E, Stuart DI, Metoz F (1999) Bioinformatics 15:305
Haupt Y, Maya R, Kazaz A, Oren M (1997) Nature 387:296
Kobe B, Kemp BE (1999) Nature 402:373
Kobe B, Heierhorst J, Kemp BE (1997) Adv Second Messenger Phosphoprotein Res 31:29
Kostic M, Matt T, Martinez-Yamout MA, Dyson HJ, Wright PE (2006) J Mol Biol 363:433
Kubbutat MH, Jones SN, Vousden KH (1997) Nature 387:299
Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ, Pavletich NP (1996) Science 274:948
Lai Z, Freedman DA, Levine AJ, McLendon GL (1998) Biochemistry 37:17005
Linke K, Mace PD, Smith CA, Vaux DL, Silke J, Day CL (2008) Cell Death Differ 15:841
Maclaine NJ, Oster B, Bundgaard B, Fraser JA, Buckner C, Lazo PA, Meek DW, Hollsberg P, Hupp TR (2008) J Biol Chem 283:28563
Marechal V, Elenbaas B, Piette J, Nicolas JC, Levine AJ (1994) Mol Cell Biol 14:7414
McCoy MA, Gesell JJ, Senior MM, Wyss DF (2003) Proc Natl Acad Sci U S A 100:1645
Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) Cell 69:1237
Neduva V, Russell RB (2005) FEBS Lett 579:3342
Neduva V, Russell RB (2006) Nucleic Acids Res 34:W350
Neduva V, Russell RB (2006) Curr Opin Biotechnol 17:465
Nenutil R, Smardova J, Pavlova S, Hanzelkova Z, Muller P, Fabian P, Hrstka R, Janotova P, Radina M, Lane D, Coates P, Vojtesek B (2005) J Pathol 207:251
Ofir-Rosenfeld Y, Boggs K, Michael D, Kastan MB, Oren M (2008) Mol Cell 32:180
Passmore LA, Barford D (2004) Biochem J 379:513–525
Pettersson S, Kelleher M, Pion E, Wallace M, Ball KL (2009) Role of MDM2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2. Biochem J 418:575–585
Popowicz GM, Czarna A, Rothweiler U, Sszwagierczak A, Krajewski M, Weber L, Holak TA (2007) Cell Cycle 6:2386
Poyurovsky MV, Jacq X, Ma C, Karni-Schmidt O, Parker PJ, Chalfie M, Manley JL, Prives C (2003) Mol Cell 12:875
Poyurovsky MV, Priest C, Kentsis A, Borden KL, Pan ZQ, Pavletich N, Prives C (2007) EMBO J 26:90
Schon O, Friedler A, Freund S, Fersht AR (2004) J Mol Biol 336:197
Shimizu H, Burch LR, Smith AJ, Dornan D, Wallace M, Ball KL, Hupp TR (2002) J Biol Chem 277:28446
Shimizu H, Saliba D, Wallace M, Finlan L, Langridge-Smith PR, Hupp TR (2006) Biochem J 397:355
Showalter SA, Bruschweiler-Li L, Johnson E, Zhang F, Bruschweiler R (2008) J Am Chem Soc 130:6472
Stevens C, Pettersson S, Wawrzynow B, Wallace M, Ball K, Zylicz A, Hupp TR (2008) FEBS J 275:4875
Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G (2008) Genes Dev 22:1337–1344
Thut CJ, Goodrich JA, Tjian R (1997) Genes Dev 11:1974
Toledo F, Wahl GM (2007) MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int J Biochem Cell Biol 39:1476
Uhrinova S, Uhrin D, Powers H, Watt K, Zheleva D, Fischer P, McInnes C, Barlow PN (2005) J Mol Biol 350:587
Uldrijan S, Pannekoek WJ, Vousden KH (2007) EMBO J 26:102
Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, Kong N, Kammlott U, Lukacs C, Klein C, Fotouhi N, Liu EA (2004) Science 303:844
Vojtesek B, Dolezalova H, Lauerova L, Svitakova M, Havlis P, Kovarik J, Midgley CA, Lane DP (1995) Oncogene 10:389
Vousden KH, Lane DP (2007) Nat Rev Mol Cell Biol 8:275
Wallace M, Worrall E, Pettersson S, Hupp TR, Ball KL (2006) Mol Cell 23:251
Wawrzynow B, Zylicz A, Wallace M, Hupp T, Zylicz M (2007) J Biol Chem 282:32603
Wawrzynow B, Pettersson S, Zylicz A, Bramham J, Worrall E, Hupp TR, Ball KL (2009) J Biol Chem 284:11517–11530
Xirodimas D, Saville MK, Edling C, Lane DP, Lain S (2001) Oncogene 20:4972
Yang Y, Ludwig RL, Jensen JP, Pierre SA, Medaglia MV, Davydov IV, Safiran YJ, Oberoi P, Kenten JH, Phillips AC, Weissman AM, Vousden KH (2005) Cancer Cell 7:547
Yu GW, Rudiger S, Veprintsev D, Freund S, Fernandez-Fernandez MR, Fersht AR (2006) Proc Natl Acad Sci U S A 103:1227
Yu GW, Allen MD, Andreeva A, Fersht AR, Bycroft M (2006) Protein Sci 15:384
Acknowledgments
This work was supported by Programme Grants to KLB (C377/A6355) and TRH (C483/A6354) from the Cancer Research UK. EW is funded by a Cancer Research UK PhD studentship (C483/A5547).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Worrall, E.G., Wawrzynow, B., Worrall, L. et al. Regulation of the E3 ubiquitin ligase activity of MDM2 by an N-terminal pseudo-substrate motif. J Chem Biol 2, 113–129 (2009). https://doi.org/10.1007/s12154-009-0019-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12154-009-0019-5